This study is in progress, not accepting new patients
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B
a study on Hepatitis B HIV/AIDS
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion:
- Principal Investigator
- Mandana Khalili
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- ID
- NCT01940341
- Phase
- Phase 3
- Lead Scientist
- Mandana Khalili
- Study Type
- Interventional
- Last Updated
- September 13, 2017